CU-00213

N/A

Report date: 2024/08/26 14:10:57
NMEFirst In Class

Base Information

Drug NameCU-00213
Drug Alias NameCU-00213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-dependent T-type calcium channel subunit alpha-1H antagonists
TargetsVoltage-dependent T-type calcium channel subunit alpha-1H
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcurex Biosciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAcurex Biosciences Corp
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A